MPP – South African Medical Research Council, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement

• Post author:GHIAA Admin
• Post published:March 8, 2023
• Post category:

Continue ReadingMPP – South African Medical Research Council, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement

MPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement

• Post author:GHIAA Admin
• Post published:March 6, 2023
• Post category:

Continue ReadingMPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement

BIND Biosciences, Inc. – Yale University, Cancer Therapeutic, Exclusive License Agreement

• Post author:GHIAA Admin
• Post published:March 3, 2023
• Post category:

Continue ReadingBIND Biosciences, Inc. – Yale University, Cancer Therapeutic, Exclusive License Agreement

National Health Service (NHS) – Pfizer/Shionogi, Antibiotic Supply Agreement

• Post author:GHIAA Admin
• Post published:March 2, 2023
• Post category:

Continue ReadingNational Health Service (NHS) – Pfizer/Shionogi, Antibiotic Supply Agreement

CEPI CfP3i Template Funding Agreement

• Post author:GHIAA Admin
• Post published:January 18, 2023
• Post category:

Continue ReadingCEPI CfP3i Template Funding Agreement

AUTM Preliminary Patent Management Agreement

• Post author:GHIAA Admin
• Post published:January 5, 2023
• Post category:

Continue ReadingAUTM Preliminary Patent Management Agreement

CEPI – VBI, COVID-19 Vaccine Development Funding Agreement

• Post author:GHIAA Admin
• Post published:December 12, 2022
• Post category:

Continue ReadingCEPI – VBI, COVID-19 Vaccine Development Funding Agreement

UnitaidExplore Sample Funding Terms and Conditions

• Post author:GHIAA Admin
• Post published:December 1, 2022
• Post category:

Continue ReadingUnitaidExplore Sample Funding Terms and Conditions

Drugs For Neglected Diseases Initiative – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement

• Post author:GHIAA Admin
• Post published:October 27, 2022
• Post category:

Continue ReadingDrugs For Neglected Diseases Initiative – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement